Literature DB >> 23013061

Oestrogen receptor beta and melanoma: a comparative study.

V de Giorgi1, A Gori, S Gandini, F Papi, M Grazzini, S Rossari, A Simoni, V Maio, D Massi.   

Abstract

BACKGROUND: Oncological research has focused on evaluating oestrogen receptors (ERs) in oestrogen-related tumours, and understanding the potential role of ERs in the pathophysiology of cancer.
OBJECTIVES: To investigate the significance of oestrogen receptor beta (ERβ) in melanoma.
METHODS: We prospectively evaluated ERβ expression in malignant melanoma (MM) tissue and adjacent healthy skin by quantitative immunohistochemistry at the Department of Dermatology of the University of Florence, from 1998 to 2010.
RESULTS: ERβ was detected with varying staining intensity in the 66 malignant melanocytic lesions. After adjusting for age and sex, we found that ERβ expression was significantly lower in melanoma tissue compared with adjacent healthy skin (P < 0·0001). We also found significantly lower ERβ levels in thick melanoma tissue compared with thin melanoma tissue. In addition, there was a positive association between Breslow thickness and the difference of ERβ expression between healthy tissue and melanoma tissue (P = 0·0004). Consistent with sex differences in melanoma survival, men showed significantly lower levels of ERβ than women in both melanoma (P = 0·05) and healthy tissues (P = 0·02).
CONCLUSIONS: ERβ expression is inversely associated with Breslow thickness and is significantly influenced by sex in MM.
© 2012 The Authors. BJD © 2012 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23013061     DOI: 10.1111/bjd.12056

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  19 in total

1.  ERβ expression and breast cancer risk prediction for women with atypias.

Authors:  Tina J Hieken; Jodi M Carter; John R Hawse; Tanya L Hoskin; Melanie Bois; Marlene Frost; Lynn C Hartmann; Derek C Radisky; Daniel W Visscher; Amy C Degnim
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.

Authors:  Bo Li; Yanru Wang; Yinghui Xu; Hongliang Liu; Wendy Bloomer; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-01-17       Impact factor: 7.396

3.  Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.

Authors:  Tina J Hieken; Amy E Glasgow; Elizabeth Ann L Enninga; Lisa A Kottschade; Roxana S Dronca; Svetomir N Markovic; Matthew S Block; Elizabeth B Habermann
Journal:  J Womens Health (Larchmt)       Date:  2020-02-27       Impact factor: 2.681

4.  Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.

Authors:  Jennifer L McQuade; Carrie R Daniel; Kenneth R Hess; Carmen Mak; Daniel Y Wang; Rajat R Rai; John J Park; Lauren E Haydu; Christine Spencer; Matthew Wongchenko; Stephen Lane; Dung-Yang Lee; Mathilde Kaper; Meredith McKean; Kathryn E Beckermann; Samuel M Rubinstein; Isabelle Rooney; Luna Musib; Nageshwar Budha; Jessie Hsu; Theodore S Nowicki; Alexandre Avila; Tomas Haas; Maneka Puligandla; Sandra Lee; Shenying Fang; Jennifer A Wargo; Jeffrey E Gershenwald; Jeffrey E Lee; Patrick Hwu; Paul B Chapman; Jeffrey A Sosman; Dirk Schadendorf; Jean-Jacques Grob; Keith T Flaherty; Dana Walker; Yibing Yan; Edward McKenna; Jeffrey J Legos; Matteo S Carlino; Antoni Ribas; John M Kirkwood; Georgina V Long; Douglas B Johnson; Alexander M Menzies; Michael A Davies
Journal:  Lancet Oncol       Date:  2018-02-12       Impact factor: 41.316

5.  Sex Differences in Melanoma.

Authors:  Matthew Robert Schwartz; Li Luo; Marianne Berwick
Journal:  Curr Epidemiol Rep       Date:  2019-05-31

Review 6.  Streamlining cutaneous melanomas in young women of the Belgian Mosan region.

Authors:  Trinh Hermanns-Lê; Sébastien Piérard
Journal:  Biomed Res Int       Date:  2014-02-25       Impact factor: 3.411

7.  In vivo skin fluorescence imaging in young Caucasian adults with early malignant melanomas.

Authors:  Gérald E Piérard; Trinh Hermanns-Lê; Sébastien L Piérard; Lucas Dewalque; Corinne Charlier; Claudine Piérard-Franchimont; Philippe Delvenne
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-08-22

Review 8.  Is oestrogen an important player in melanoma progression?

Authors:  Marcelina E Janik; Klaudyna Bełkot; Małgorzata Przybyło
Journal:  Contemp Oncol (Pozn)       Date:  2014-11-05

9.  Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines.

Authors:  Monica Marzagalli; Lavinia Casati; Roberta M Moretti; Marina Montagnani Marelli; Patrizia Limonta
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

10.  Medium Sized Congenital Melanocytic Nevus with Suspected Progression to Melanoma during Pregnancy: What's the Best for the Patient?

Authors:  Georgi Tchernev; Gabriela Atanasova Dzhelyatova; Uwe Wollina; Ilia Lozev; Torello Lotti
Journal:  Open Access Maced J Med Sci       Date:  2018-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.